Amanda Green
Associate Director - Quality Assurance Orna Therapeutics
Seminars
Thursday 26th February 2026
Roundtable Discussion: Establishing Foundational Principles to Translate Emerging RNA Modalities into GMP & QC Frameworks
1:30 pm
- How to define phase-appropriate analytical and QC strategies for novel RNA formats amid evolving regulatory expectations
- Bridging R&D and GMP mindsets to enable compliant yet flexible analytical development
- Encouraging data transparency and alignment to accelerate harmonized quality standards across emerging RNA modalities
